David Meek

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About David Meek

David Meek was last confirmed as Board Member at Cullinan Therapeutics, Inc. (CGEM) in a filing dated May 16, 2024. David Meek was last confirmed as Board Member at uniQure N.V. (QURE) in a filing dated April 28, 2023. Cullinan Therapeutics, Inc. reported in an 8-K filed May 15, 2024 that David Meek was appointed Class I director, effective May 15, 2024.

“On May 9, 2024, the Board of Directors (the "Board") of the Company appointed David Meek as a Class I director, effective May 15, 2024.”

Cullinan Therapeutics, Inc. Form 8-K, filed May 15, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize David Meek's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Cullinan Therapeutics, Inc. (CGEM)
Board Member

Proxy statement

2024-01-01–2024-05-16

Last confirmed by a filing; no departure on record
uniQure N.V. (QURE)
Board Member

Proxy statement

2018-01-01–2023-04-28

Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Cullinan Therapeutics, Inc.

CGEM

Board Member

Since 2024-01-01, last confirmed 2024-05-16

uniQure N.V.

QURE

Board Member

Since 2018-01-01, last confirmed 2023-04-28

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Appointed: Class I director Cullinan Therapeutics, Inc. (CGEM)
2024-05-15